Free Consultations 24/7
Our law firm has been dedicated to clients like you for 90 years. We care about each one of our clients.
Cases We Handle
from auto accidents to defective product injuries to workers’ compensation claims, we’re here to help.
We value building relationships with the many people and organizations that make Cleveland a great place to live.
Our law firm has a trusted team of personal injury lawyers who have been helping injured people in Cleveland.
Marketed as a safe way millions of men can treat low testosterone conditions, topical application drugs for “Low T,” like gels and patches, are being connected to dangerous medical risks. Lawsuits related to use of low testosterone therapy drugs are happening now. Nurenberg, Paris, Heller & McCarthy can help.
A study published in The Journal of the American Medical Association reports a 30 percent increase in the risk of heart attack, stroke, pulmonary embolism, deep venous thrombosis, and even death in men who take topical testosterone therapy drugs, such as AndroGel®.
Another study of more than 55,000 male patients reveals that men over age 65 are twice as likely to have a heart attack after taking testosterone replacement drugs for as little as three months. The risk of heart attack also doubles for men under age 65 if they have a history of heart disease.
The same study also concludes that, compared to Low T drugs, erectile dysfunction drugs–also marketed as methods to increase male sexual performance–are much less likely to increase the risk of heart attack in men under age 65 who have a history of heart disease.
These risks have led to a U.S. Food and Drug Administration (FDA) investigation into the link between Low T treatments and cardiovascular problems. The FDA announced that it is reevaluating its opinion on the safety of testosterone replacement drugs.
Studies like these show that low testosterone therapy significantly increases hematocrit and hemoglobin levels within the first 90 days of application (one therapy cycle). During this time, risk of myocardial infarction (heart attack) is doubled.
This risk factor shows that testosterone replacement therapy dramatically increases your red blood cell count, creating “thick blood” or an increased chance for cardiovascular injuries.
While no large-scale tests have been done to determine if the benefits of low testosterone therapy outweighs the risks associated with it, a 2004 Institute of Medicine study on the benefits of testosterone replacement drugs found that “there is no clear evidence for benefit” for any of the health outcomes examined.
If you suffered a cardiac episode after using topical Low T drugs, your injuries may be connected to the use of the medication. The drug injury lawyers at Nurenberg Paris are here to help you get the compensation you’re owed for your injury-related expenses. Call our legal team today at (216) 230-6352 or complete a free, confidential consultation.
AndroGel®is a registered trademark of AbbVie Inc. and is used here only for identification purposes.This law firm is not affiliated with, sponsored by, or associated with AbbVie Inc., Pfizer, Inc., Eli Lily & Co., The Journal of the American Medical Association, the Institute of Medicine, or the U.S. Food and Drug Administration.